Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 129 | 172 | +43 |
| Shares | 53.8M | 67.4M | +13.7M (+25.4%) |
| Value | $494.9M | $762.7M | +$267.8M (+54.1%) |
New holders (59)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (16)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| J. Goldman & Co LP | 135,000 | $1.24M |
| HRT Financial LP | 124,924 | $1.15M |
| Susquehanna Fundamental Investments, LLC | 111,582 | $1.03M |
| Bridgeway Capital Management, LLC | 95,400 | $877.7K |
| Jacobs Levy Equity Management, Inc | 70,015 | $644.1K |
| Acuta Capital Partners, LLC | 57,141 | $525.7K |
| PharVision Advisers, LLC | 23,868 | $219.6K |
| Algert Global LLC | 16,550 | $152.3K |
| Sanctuary Advisors, LLC | 13,154 | $121.0K |
| Martingale Asset Management L P | 10,563 | $97.2K |
| BIT Capital GmbH | 6,090 | $56.0K |
| Clear Street Markets LLC | 2,917 | $26.8K |
| Macquarie Group Ltd | 2,495 | $23.0K |
| Rise Advisors, LLC | 348 | $3.20K |
| Clearstead Advisors, LLC | 4 | $37 |
| Summit Wealth Group LLC | 533 | – |